AtriCure(us:ATRC)

    30.72

    +2.23%

    Updated on 2024-12-22

    Open:30.00
    Close:30.72
    High:31.02
    Low:29.56
    Pre Close:30.05
    Volume:768305.00
    Amount:23.48M
    Turnover:1.58%
    Shares:48.75M
    MarketCap:1.50B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3024250596794103.93%2597102
    2024-03-3125649339243101.98%3483116
    2023-12-312634711188199.13%39102103
    2023-09-302434506680195.09%279295
    2023-06-302404473141594.47%258891
    2023-03-312364415304693.46%349078
    2022-12-312374506766196.79%2774105
    2022-09-302334434610995.48%248491
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Vanguard Group Inc46219339.49%-131052-2.76%
    2024-06-30Blackrock Inc.46157919.48%3847339.09%
    2024-06-30Alliancebernstein L.P.42049798.64%55223815.12%
    2024-06-30Champlain Investment Partners, Llc26749455.49%-6055-0.23%
    2024-06-30Fmr Llc21123534.34%-364922-14.73%
    2024-06-30Macquarie Group Ltd19980494.10%58482441.38%
    2024-06-30First Light Asset Management, Llc19647034.04%58184342.08%
    2024-06-30Hood River Capital Management Llc17752433.65%1775243
    2024-06-30Wellington Management Group Llp15378513.16%-102311-6.24%
    2024-06-30State Street Corp12818542.63%951818.02%

    About

    AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
    Address:7555 Innovation Way

    Market Movers